Anastasis Nikolaou Form 4 Acrivon Therapeutics / Andreas Hadjimichael ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Chione Ltd

(Last) (First) (Middle)

SIMOU MENARDOU 5,

KIFISIA COURT, OFFICE 225

(Street)

LARNACA G4 6015

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Acrivon Therapeutics, Inc. [ ACRV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/17/2022

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/17/2022		P		400,000	A	$12.5	3,856,597	D(2)(3)(4)(5)
Common Stock	11/17/2022		C		3,445,940	A	(1)	3,856,597	D(2)(3)(4)(5)
Common Stock	11/17/2022		C		10,657	A	(1)	3,856,597	D(2)(3)(4)(5)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series A-1 Preferred Stock	(1)	11/17/2022		C			8,497,692	(1)	(1)	Common Stock	3,445,940	$0	0	D(2)(3)(4)(5)
Series B Preferred Stock	(1)	11/17/2022		C			26,281	(1)	(1)	Common Stock	10,657	$0	0	D(2)(3)(4)(5)

1. Name and Address of Reporting Person^*

Chione Ltd

(Last) (First) (Middle)

SIMOU MENARDOU 5,

KIFISIA COURT, OFFICE 225

(Street)

LARNACA G4 6015

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

Czernik Marcin

(Last) (First) (Middle)

C/O CHIONE LIMITED SIMOU MENARDOU 5,

KIFISIA COURT, OFFICE 225

(Street)

LARNACA G4 6015

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

Hadjimichael Andreas

(Last) (First) (Middle)

C/O CHIONE LIMITED SIMOU MENARDOU 5,

KIFISIA COURT, OFFICE 225

(Street)

LARNACA G4 6015

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

Nikolaou Anastasis

(Last) (First) (Middle)

C/O CHIONE LIMITED SIMOU MENARDOU 5,

KIFISIA COURT, OFFICE 225

(Street)

LARNACA G4 6015

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

Smolokowski Wiaczeslaw

(Last) (First) (Middle)

CHALET LENOTCHKA CH.DE BARNOUD

1885 CHESIERES

(Street)

SWITZERLAND V8 1885

(City) (State) (Zip)

Explanation of Responses:

1. Each share of Series A-1 Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Stock") was automatically converted into Common Stock on a 2.466 to 1 share basis, without payment of further consideration, in connection with the closing of the issuer's initial public offering. The conversion prices per share of Common Stock for the Series A-1 Preferred Stock and Series B Preferred Stock were $5.6225 and $14.0745, respectively. The Preferred Stock had no expiration date.

2. Shares owned directly by Chione Limited ("Chione").

3. Chione's directors, Marcin Czernik, Andreas Hadjimichael and Anastasis Nikolaou, and its sole shareholder, Wiaczeslaw Smolokowski, may be deemed to share beneficial ownership of the shares directly owned by Chione.

4. Each reporting person states that neither the filing of this Form 4 nor anything herein shall be deemed an admission that such person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Act"), or otherwise, the beneficial owner of any securities covered by this Form 4. Each reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities.

5. Each reporting person may be deemed to be a member of a group with respect to the issuer or securities of the issuer for purposes of Section 13(d) or 13(g) of the Act. Each reporting person declares that neither the filing of this Form 4 nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, a member of a group with respect to the issuer or securities of the issuer.

Remarks:

Exhibit Index Exhibit 24.1 - Power of Attorney, dated October 10, 2022, made by Marcin Czernik and Chione Limited in favor of Shalom Leaf (filed with the Form 3, filed on behalf of Chione Limited et al on 11/09/22) Exhibit 24.2 - Power of Attorney, dated October 10, 2022, made by Andreas Hadjimichael and Chione Limited in favor of Shalom Leaf (filed with the Form 3, filed on behalf of Chione Limited et al on 11/09/22) Exhibit 24.3 - Power of Attorney, dated October 10, 2022, made by Wiaczeslaw Smolokowski in favor of Shalom Leaf (filed with the Form 3, filed on behalf of Chione Limited et al on 11/09/22) Exhibit 24.4 - Power of Attorney, dated October 10, 2022, made by Anastasis Nikolaou in favor of Shalom Leaf (filed with the Form 3/A, filed on behalf of Chione Limited et al on 11/14/22) Exhibit 99.1 - Joint Filer Information (filed with the Form 3/A, filed on behalf of Chione Limited et al on 11/14/22) Exhibit 99.2 - Joint Filing Agreement (filed with the Form 3/A, filed on behalf of Chione Limited et al on 11/14/22)

	Chione Limited, by /s/ Shalom Leaf, as attorney-in fact by power of attorney	11/21/2022
	Marcin Czernik, by /s/ Shalom Leaf, as attorney-in fact by power of attorney	11/21/2022
	Andreas Hadjimichael, by /s/ Shalom Leaf, as attorney-in fact by power of attorney	11/21/2022
	Anastasis Nikolaou, by /s/ Shalom Leaf, as attorney-in fact by power of attorney	11/21/2022
	Wiaczeslaw Smolokowski, by /s/ Shalom Leaf, as attorney-in fact by power of attorney	11/21/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.